Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.
Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.
Ventaris Surgical is a medical equipment company that provides surgical instruments to specialists.
AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.
MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.
89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
Cortica provides neurological therapies for children with autism and other developmental differences.
CuraSen Therapeutics is a biopharmaceutical company that develops orphan drugs to treat neurodegenerative diseases
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.
Nalu Medical is a medical technology company that develops innovative solutions for patients with chronic neuropathic pain.
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better.
Eargo specializes in the design and development of hearing aids.
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.
Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
IntelyCare is revolutionizing healthcare staffing, scheduling, and training by offering an enterprise workforce management platform.
LimFlow SA is a venture-backed medical device company.
Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.
Longitude Capital has invested in 62 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Longitude Capital's top investment sectors include Health Care, Medical Device, Therapeutics, Biotechnology, Medical. The firm invests across 23 different industry categories.
Among tracked funding rounds, VeraDermics received $384.4M in a Post-IPO Equity round. Longitude Capital's total known invested capital is $4.7B.
Longitude Capital's average investment size is $75.0M across its portfolio of 62 companies.
Recent Longitude Capital portfolio additions include Quanta Therapeutics, VeraDermics, Polares Medical, Ventaris Surgical, AirNexis Therapeutics. These companies were founded in 2020 or later.